Literature DB >> 3496298

Modification of expression of the malignant phenotype in radiation-initiated cells.

M N Gould, H Watanabe, K Kamiya, K H Clifton.   

Abstract

Carcinogenesis is a multistage process consisting minimally of initiation and promotion/progression stages. Radiation and many environmental xenobiotics are potent initiating agents. We have shown that initiation of carcinogenesis in vivo by these agents is a common cellular event. In the irradiated thyroid (5 Gy) at least one in 20 cells is initiated. Initiation by both radiation and chemicals has also been shown to be a common cellular event in the mammary gland. Initiation therefore is most likely not the sole rate-limiting event in the carcinogenic process. The propensity of the initiated cell to express the malignant phenotype is modulated by many factors, including environmental chemicals and physiological and genetic factors. Scopal and abscopal physiological factors can either enhance or suppress the progression of initiated cells to a frank tumour. For example, prolactin enhances the rate of progression of radiation and chemically initiated mammary tumours while glucocorticoids suppress this progression. TSH enhances the progression of radiation-initiated thyroid tumours while a scopal factor associated with unirradiated thyroid cells suppresses progression of this tumour type.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496298     DOI: 10.1080/09553008714551371

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  2 in total

1.  Quantitative and molecular comparison of initiation frequency of mammary carcinogenesis by radiation and chemical carcinogens.

Authors:  M N Gould; K H Clifton; K Kamiya; B Wang; R Zhang
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

Review 2.  Genetic regulation of mammary carcinogenesis in the rat by susceptibility and suppressor genes.

Authors:  M N Gould; R Zhang
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.